Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pierre Fabre
Biotech
Scorpion bags $553M deal for preclinical lung cancer assets
Pierre Fabre has inked a deal to work with Scorpion Therapeutics on two of the biotech’s preclinical oncology candidates.
Gabrielle Masson
Apr 4, 2023 8:00am
Forte taps new exec amid shareholder dissent—Chutes & Ladders
Jun 10, 2022 9:30am
Pierre Fabre and Roche extend pact on companion diagnostic for cancer
May 18, 2018 9:14am
Pierre Fabre forms connected underwear collaboration
May 14, 2018 8:40am
Pierre Fabre buys up Igenica preclinical I-O meds
May 24, 2017 5:52am
EuroBiotech: More Articles of Note
May 11, 2017 9:19am
